Home/Filings/4/0001415889-23-015125
4//SEC Filing

Helling Dennis 4

Accession 0001415889-23-015125

CIK 0001651561other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 8:50 PM ET

Size

11.4 KB

Accession

0001415889-23-015125

Insider Transaction Report

Form 4
Period: 2023-11-03
Transactions
  • Disposition to Issuer

    Common Stock

    2023-11-0382,67629,433 total
  • Disposition to Issuer

    Common Stock

    2023-11-033,79225,641 total
  • Disposition to Issuer

    Common Stock

    2023-11-0325,6410 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-11-032,3690 total
    Exercise: $14.00Exp: 2027-01-30Common Stock (2,369 underlying)
Footnotes (4)
  • [F1]Upon the consummation of the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger, by and among Tabula Rasa HealthCare, Inc. (the "Company"), Locke Buyer, LLC and Locke Merger Sub, Inc., dated August 5, 2023 (the "Merger Agreement"), 82,676 shares of common stock of the Company ("Common Stock") were converted into the right to receive a cash payment of $868,098, representing the product obtained by multiplying (x) aggregate number of shares of Common Stock owned by the reporting person, by (y) the offer price ($10.50).
  • [F2]Upon the consummation of the Merger, pursuant to the Merger Agreement, 3,792 outstanding restricted stock units ("RSUs") were cancelled and converted into the right to receive a cash payment of $39,816, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSUs, by (y) the offer price ($10.50).
  • [F3]Upon the consummation of the Merger, pursuant to the Merger Agreement, 25,641 unvested restricted stock awards ("RSAs") were cancelled and converted into the right to receive a cash payment of $269,230.50, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSAs, by (y) the offer price ($10.50).
  • [F4]Pursuant to the Merger Agreement, any stock option with an exercise price per share of Common Stock that was equal to or greater than the offer price ($10.50) was to be cancelled for no consideration. Accordingly, upon the consummation of the Merger, 2,369 stock options were cancelled for no consideration, as the exercise price per share of Common Stock was $14.

Issuer

Tabula Rasa HealthCare, Inc.

CIK 0001651561

Entity typeother

Related Parties

1
  • filerCIK 0001700642

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 8:50 PM ET
Size
11.4 KB